PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Status:
RECRUITING
Trial end date:
2032-06-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, open-label, two-arm phase 2 trial that will evaluate whether the use of Pulsed Low-Dose-Rate radiation technique, as compared to standard radiation, is associated with reduced rates of clinically significant esophagitis during and following chemoradiation.
Phase:
PHASE2
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Drug Therapy Heart Rate Induction Chemotherapy Radiation Surgical Procedures, Operative